Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm2 intrauterine device: Results of a 3-year, single-center, randomized phase 4 study

Perelló-Capó, Josep; Estadella-Tarriel, Josep; Gich-Saladich, Ignasi; Bailón-Queiruga, Marta; Llurba, Elisa; Calaf-Alsina, Joaquim

doi:10.1016/j.contraception.2023.110127

Contraception

2023

DOI: 10.1016/j.contraception.2023.110127

|View full text |Cite

Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm2 intrauterine device: Results of a 3-year, single-center, randomized phase 4 study

Josep Perelló-Capó¹,

Josep Estadella-Tarriel²,

Ignasi Gich-Saladich³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial

Perelló-Capó,

Estadella-Tarriel,

Gich-Saladich

et al. 2024

Contraception

View full text Add to dashboard Cite

Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial

Perelló-Capó,

Estadella-Tarriel,

Gich-Saladich

et al. 2024

Contraception

View full text Add to dashboard Cite

Levonorgestrel maintains goal-directed behavior in habit-trained intact female rats

VonDoepp,

Mohammed,

Dougherty

et al. 2024

Hormones and Behavior

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm2 intrauterine device: Results of a 3-year, single-center, randomized phase 4 study

Cited by 2 publications

References 29 publications

Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial

Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial

Levonorgestrel maintains goal-directed behavior in habit-trained intact female rats

Contact Info

Product

Resources

About